File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Efficacy of telbivudine vs lamivudine at 2 years in patients with hbeag-positive chronic hepatitis B who are eligible for treatment based on guidelines

TitleEfficacy of telbivudine vs lamivudine at 2 years in patients with hbeag-positive chronic hepatitis B who are eligible for treatment based on guidelines
Authors
Rasenack, JPoynard, TLai, CLGane, EBrown, NAHeathcote, J
Issue Date2007
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
Citation
Journal of Hepatology, v. 46 n. Suppl 1, p. S195 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/102225
ISSN
0168-8278
2021 Impact Factor: 30.083
2020 SCImago Journal Rankings: 7.112

 

DC FieldValueLanguage
dc.contributor.authorRasenack, Jen_HK
dc.contributor.authorPoynard, Ten_HK
dc.contributor.authorLai, CLen_HK
dc.contributor.authorGane, Een_HK
dc.contributor.authorBrown, NAen_HK
dc.contributor.authorHeathcote, Jen_HK
dc.date.accessioned2010-09-25T20:22:04Z-
dc.date.available2010-09-25T20:22:04Z-
dc.date.issued2007en_HK
dc.identifier.citationJournal of Hepatology, v. 46 n. Suppl 1, p. S195en_HK
dc.identifier.issn0168-8278en_HK
dc.identifier.urihttp://hdl.handle.net/10722/102225-
dc.languageengen_HK
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhepen_HK
dc.relation.ispartofJournal of Hepatologyen_HK
dc.rightsJournal of Hepatology. Copyright © Elsevier BV.en_HK
dc.titleEfficacy of telbivudine vs lamivudine at 2 years in patients with hbeag-positive chronic hepatitis B who are eligible for treatment based on guidelinesen_HK
dc.typeConference_Paperen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0168-8278&volume=46&issue=Suppl 1&spage=S195&epage=&date=2007&atitle=Efficacy+of+telbivudine+vs+lamivudine+at+2+years+in+patients+with+hbeag-positive+chronic+hepatitis+B+who+are+eligible+for+treatment+based+on+guidelinesen_HK
dc.identifier.emailLai, CL: hrmelcl@hku.hken_HK
dc.identifier.authorityLai, CL=rp00314en_HK
dc.identifier.hkuros152471en_HK
dc.identifier.volume, v. 46 n. Suppl 1en_HK
dc.identifier.issueSuppl 1en_HK
dc.identifier.spage195en_HK
dc.identifier.issnl0168-8278-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats